Amphiphilic polynucleotides

PROPHYLACTIC OR THERAPEUTIC AGENT FOR AT LEAST ONE TYPE OF CANCER SELECTED FROM GROUP CONSISTING OF PANCREATIC CANCER, LUNG CANCER, COLORECTAL CANCER, CHOLANGIOCARCINOMA AND LIVER CANCER, PROPHYLACTIC OR THERAPEUTIC AGENT FOR SAID CANCER WHICH IS USED IN COMBINATION DRUG IN COMBINATION WITH SAID AGENT, COMBINATION DRUG COMPRISING SAID AGENTS, AND METHOD FOR SCREENING FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER

COMPOSITIONS AND METHODS FOR REGULATION OF CELL ACTIVITY VIA MODULATION OF BETA-CYTOKINE ACTIVITY

Compositions and Methods for Modulation of SMN2 Splicing in a Subject

COMPOSITIONS AND METHODS FOR THE DELIVERY OF AGENTS TO BIOLOGICAL TARGETS

ANTAGONIST OF PCSK9

Reducing intron retention

USE OF SEPT9 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

Materials and methods for treatment of Duchenne Muscular Dystrophy

ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF

Hybridosomes, compositions comprising the same, processes for their production and uses thereof

BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES

SCALABLE TRIO GUIDE RNA APPROACH FOR INTEGRATION OF LARGE DONOR DNA

RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE

IMMUNOLOGICALLY COMPATIBLE AND REVERSIBLE UNIVERSAL PLURIPOTENT STEM CELL AND APPLICATION THEREOF

Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) Expression

MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS

COMPOSITIONS AND METHODS FOR TREATING DISORDERS ASSOCIATED WITH LOSS-OF-FUNCTION MUTATIONS IN SYNGAP1

GRNA FOR KNOCKING OUT PIG XENOANTIGEN GENE, AND APPLICATION THEREOF

ENGINEERED NUCLEIC ACIDS AND USES THEREOF

HETERONUCLEIC ACID CONTAINING MORPHOLINO NUCLEIC ACID

CHANNEL MODULATORS

METHODS AND COMPOSITIONS FOR TREATING ATAXIA TELANGIECTASIA

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION

Guide RNA that targets a mutant human guanylate cyclase 2A allele

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY

Nucleoporins as drug targets for anti-proliferative therapeutics

COMPOSITIONS AND METHODS FOR CORRECTING LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2C USING EXON SKIPPING

Compositions for FNIP1/FNIP2 Gene Modulation and Methods Thereof

COMPOUNDS AND METHODS FOR REDUCING PSD3 EXPRESSION

COMPOSITIONS COMPRISING EXOGENOUS HOMOLOGOUS DNA AND USES THEREOF

COMPOSITIONS AND METHODS FOR INTRANASAL TREATMENT WITH DOUBLE STRANDED RNA

Optimised Methods for Cleavage of Target Sequences

HYDROGEL-MATRIX ENCAPSULATED OLIGONUCLEOTIDES AND METHODS FOR FORMULATING AND USING ENCAPSULATED OLIGONUCLEOTIDES

Segmented Nucleic Acids

METHOD OF STIMULATING PROLIFERATION OF A CELL

ENGINEERED INCOHERENT FEED FORWARD LOOP AND USES THEREOF

DOUBLE STRANDED RNA TARGETING ANGIOPOIETIN-LIKE 3 (ANGPTL-3) AND METHODS OF USE THEREOF

MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF

IMPROVED SCAFFOLDS FOR MULTIPLEXED INHIBITORY RNA

CHROMATIN REMODELERS TO ENHANCE TARGETED GENE ACTIVATION

Base editing of PCSK9 and methods of using same for treatment of disease

ANTISENSE OLIGONUCLEOTIDE OF CALM2

PREVENTION OR TREATMENT OF ANEURYSMS USING MIR-33B INHIBITOR

RIG-I Agonists and Methods of Using Same

MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

TRANSLATION ENHANCER, TRANSLATION TEMPLATE MRNA, TRANSCRIPTION TEMPLATE DNA, PRODUCTION METHOD OF A TRANSLATION TEMPLATE MRNA, AND PRODUCTION METHOD OF A PROTEIN

METHODS AND COMPOSITIONS COMPRISING BRD9 ACTIVATING THERAPIES FOR TREATING CANCERS AND RELATED DISORDERS

TARGETED BASE EDITING OF THE USH2A GENE

Composition for preventing or treating diseases caused by overexpression of chemokine CXCL1, containing death receptor inhibitor as active ingredient

PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD CHOLESTEROL, PREVENTING OR TREATING CARDIOVASCULAR DISEASES AND REDUCING INFLAMMATION

METHODS AND SYSTEMS FOR NONINVASIVE CONTROL OF BRAIN CELLS AND RELATED VECTORS AND COMPOSITIONS

METHODS AND COMPOSITIONS FOR APTAMER-DRIVEN SURFACE FORMULATION OF SELF-FORMING POLYNUCLEOTIDE NANOPARTICLES

COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION

COMPOSITIONS AND METHODS FOR INCREASING SODIUM CURRENT IN CARDIAC CELLS

MODIFIED SHORT-INTERFERING RNA COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER

METHODS AND MEANS FOR EFFICIENT DKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-MRNA

NUCLEIC ACID COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

DIRECT REPLACEMENT GENOME EDITING

ANTISENSE NUCLEIC ACIDS

TREATMENT OF ALT CANCERS

ENGINEERED ONCOLYTIC ADENOVIRUS

Purified Enriched Population Exosomes Derived From Individuals With A Chronic Progressive Lung Disease For Noninvasive Detection, Staging, And Medical Monitoring Of Disease Progression

GENOME ENGINEERING USING CRISPR RNA-GUIDED INTEGRASES

MULTIMERIC OLIGONUCLEOTIDES WITH DIVIDED STRANDS

Plant regulatory elements and uses thereof

METHOD FOR IDENTIFING A MARKER FOR A BIOLOGICAL INTERACTION

COMPOSITIONS AND METHODS FOR MODULATING RPGR EXPRESSION

COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS

COMPOSITIONS AND METHODS FOR TREATING CHRONIC MYELOMONOCYTIC LEUKEMIA

METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IGM RESPONSES

ANTISENSE NUCLEIC ACID INDUCING SKIPPING OF EXON 51

Promoter Sequences for In Vitro and In Vivo Expression of Gene Therapy Products in CD3+ Cells

MICRORNAS FOR THE PREVENTION OF CLINICAL VENOUS THROMBOEMBOLIC DISEASE

ANTISENSE SEQUENCES FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

1'-ALKYL MODIFIED RIBOSE DERIVATIVES AND METHODS OF USE

CARDIAC CELL REPROGRAMMING WITH MICRORNAS AND OTHER FACTORS

HYBRID htiRNA / NANOPARTICLE COMPLEX AND USE THEREOF FOR TREATING A DISEASE OF THE DIGESTIVE SYSTEM

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

PRODUCTS AND COMPOSITIONS

Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)

MODIFIED SALMON WHICH PRODUCE STERILE OFFSPRING

METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS BY SUPPRESION OF TRANSCRIPTION FACTORS

CAS9 mutant genes and polypeptides encoded by same

DOUBLE-STRANDED OLIGONUCLEOTIDE, COMPOSITION AND CONJUGATE COMPRISING DOUBLE-STRANDED OLIGONUCLEOTIDE, PREPARATION METHOD THEREOF AND USE THEREOF

Targeted Inhibition Using Engineered Oligonucleotides

OLIGONUCLEOTIDES CONJUGATES COMPRISING 7'-5'-ALPHA-ANOMERIC-BICYCLIC SUGAR NUCLEOSIDES

RNA-guided transcriptional regulation

Anti-transferrin receptor antibodies and uses thereof

METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1

USE OF MIRNA-485 INHIBITORS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Rotavirus vaccines

ANTISENSE OLIGONUCLEOTIDE OF ATN1

Genetic elements driving circular RNA translation and methods of use

TDP-43 MODULATING AGENTS AND USES THEREOF

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use

UNC13A antisense oligonucleotides

COMPOUNDS AND METHODS FOR MODULATING KCNQ2

MicroRNA-based logic gates and uses thereof

Compositions and Methods for Gene Editing

Composition for preventing or treating keloids or hypertrophic scars

4'-O-METHYLENE PHOSPHONATE NUCLEIC ACIDS AND ANALOGUES THEREOF

RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX

Deaminase-based RNA sensors

TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS

ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Organelle genome modification using polynucleotide guided endonuclease

OLIGONUCLEOTIDES FOR MODULATING CD73 EXON 7 SPLICING

Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

DIAGNOSTIC METHODS USING PCG-1A EXPRESSION

METHOD OF DELIVERING NUCLEIC ACID TO IMMUNE CELLS USING RBCEV

HYPERBRANCHED POLYMERS AND POLYPLEXES AND DNA OR RNA DELIVERY SYSTEMS INCLUDING THE SAME

CELL-TARGETED NANOPARTICLES TO INHIBIT RNA CARGO

USE OF SARAF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

DIAGNOSTIC METHODS USING SIRT1 EXPRESSION

RNAI INDUCED HUNTINGTIN GENE SUPPRESSION

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Compositions and methods for TTR gene editing and treating ATTR amyloidosis

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES

COMPOUNDS AND METHODS FOR MODULATING SPLICING OF PRE-MRNA

METHODS OF PREPARING OLIGONUCLEOTIDE COMPOSITIONS USING ULTRAFILTRATION/DIAFILTRATION

ONCOLYTIC VIRAL VECTORS AND USES THEREOF

HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Optimized CRISPR-Cas nucleases and base editors and methods of use thereof

COMPOSITIONS AND METHODS COMPRISING IMPROVED GUIDE RNAs

Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential (CHIP) With Lymphocyte Antigen 75 (LY75), Cluster Of Differentiation 164 (CD164), Or Poly(ADP-Ribose) Polymerase 1 (PARP1) Inhibitors

Selective Antisense Compounds and Uses Thereof

ANTISENSE NUCLEIC ACID TARGETING APOC3

Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection

Compositions for Modulating C9ORF72 Expression

NUCLEASE-MEDIATED MODULATION OF GENE EXPRESSION

Angleman syndrome antisense treatment

MODULATING STRESS RESPONSES BY A NOVEL CHROMATIN-ASSOCIATED GUIDE RNA DERIVED FROM TRANSFER RNA

Transthyretin (TTR) iRNA compositions and methods of use thereof

SYNTHETIC GUIDE MOLECULES, COMPOSITIONS AND METHODS RELATING THERETO

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF KRAS BY ASYMMETRIC DOUBLE-STRANDED RNA

MODIFIED DOUBLE-STRANDED RNA AGENTS

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

Compositions and methods for treating allergic inflammatory conditions

Compositions for treatment of polycystic kidney disease

TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF

NOVEL CRISPR ENZYMES AND SYSTEMS

EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER

Polymerizable compound, compound, and method for producing boranophosphate oligomer

METHODS FOR REDUCING HTT EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING ALPHA-1 ANTITRYPSIN EXPRESSION

POLY(BETA-AMINO ESTER)-CO-POLYETHYLENE GLYCOL (PEG-PBAE-PEG) POLYMERS FOR GENE AND DRUG DELIVERY

METHODS OF TREATING SPINAL MUSCULAR ATROPHY

STABILIZATION OF RNA FOR EXOGENOUS RNAi AGRICULTURAL APPLICATIONS AND FORMULATIONS

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD

COMPOSITIONS AND METHODS FOR GENE EDITING

OVERLAPPING THERAPEUTIC STRATEGIES FOR CYSTINOSIS TREATMENT AND COSMETIC SKIN DARKENING

KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Increasing gene expression

RNA STABILIZATION

Compositions comprising reversibly modified oligonucleotides and uses thereof

Nanoparticle compositions containing sugar functionalized nucleic acid carriers

Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein

USE OF MIRNA-485 INHIBITORS FOR TREATING TAUOPATHY

Treatment Of Glaucoma With Rho Guanine Nucleotide Exchange Factor 12 (ARHGEF12) Inhibitors

SERINE PROTEASE INHIBITORS FOR SUPPRESSING OR PREVENTING ANAPHYLACTIC REACTION

MICRORNA COMPOSITIONS AND METHODS OF USE

Antisense nucleic acid inducing skipping of exon 51

OLIGOMERIC COMPOUNDS COMPRISING BACKBONE CONSTRAINED MACROCYCLES

RNAS FOR COMPLEMENT INHIBITION

STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Compositions and methods for delivery of nucleic acids to cells

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSING OF METHYLATION-CONTROLLED J-PROTEIN (MCJ)

CLOSED-END DNA PRODUCTION WITH INVERTED TERMINAL REPEAT SEQUENCES

Compositions and methods of treating facioscapulohumeral muscular dystrophy

AAV-Mediated Targeting of MIRNA in the Treatment of X-Linked Disorders

METHODS AND COMPOSITIONS COMPRISING TRANS-ACTING TRANSLATIONAL ACTIVATORS

Bacterial Biomarker

PRODUCTS AND COMPOSITIONS

PRODUCTS AND COMPOSITIONS

RAAV-MEDIATED IN VIVO DELIVERY OF SUPPRESSOR TRNAS

CHEMICALLY MODIFIED OLIGONUCLEOTIDES WITH IMPROVED SYSTEMIC DELIVERY

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

MIR-149-3P AND METHOD FOR TREATING METABOLIC DISEASE USING THE SAME

GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY

TOPICAL DELIVERY OF RNA INTERFERENCE AGENTS USING IONIC LIQUID

Sequential gene editing in primary immune cells

COMPOUNDS AND METHODS FOR REDUCING APOE EXPRESSION

Minimal UTR sequences

Compositions and methods for delivery of nucleic acids to cells

Adeno-associated virus for activating RNA-NEAT1 over-expression and applications thereof

METHODS AND COMPOSITIONS FOR STUDYING CELL EVOLUTION

TRANSPOSON-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND USES THEREOF

ENHANCED PLACENTAL STEM CELLS AND USES THEREOF

ANTICANCER ADJUVANT AND PHARMACEUTICAL COMPOSITION FOR TREATING ANTICANCER-AGENT-RESISTANT CANCER, AND KIT COMPRISING SAME

METHODS AND MATERIALS FOR TREATING CANCER

Methods and compositions for reducing pathogenic isoforms

COMPOSITIONS COMPRISING BACTERIALLY DERIVED MINICELLS AND METHODS OF USING THE SAME

Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same

Optimized anti-FLT1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders

Non-human animals comprising a humanized TTR locus and methods of use

RNAi CONSTRUCTS AND METHODS FOR INHIBITING LPA EXPRESSION

Modified U6 promoter system for tissue specific expression

Methods and Compositions for Directed Genome Editing

Composition for preventing or treating cognitive dysfunction including inhibitor or MECP2 expression

VECTORIZED ANTIBODIES (vAb) AND USES THEREOF

CRISPR enzymes and systems

NOVEL PROTOSPACER ADJACENT MOTIF SEQUENCE AND METHOD FOR MODIFYING TARGET NUCLEIC ACID IN GENOME OF CELL BY USING SAME

Treatment Of Inflammatory Diseases With RAS Protein Activator Like 3 (RASAL3) Inhibitors

GENOME EDITING USING CRISPR IN CORYNEBACTERIUM

THERAPY OF RAS-DEPENDENT CANCERS

Ribozyme-mediated RNA Assembly and Expression

ANTISENSE NUCLEIC ACID THAT INDUCES SKIPPING OF EXON 50

COMPOSITIONS COMPRISING MODIFIED CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

TOBACCO PLANT BODY AND METHOD FOR PRODUCING SAME

Multi-conjugate of siRNA and preparing method thereof

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF ALPHA-1 ANTITRYPSIN BY DOUBLE-STRANDED RNA

Effector proteins and methods of use

Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Modified compounds and uses thereof

Methods and compositions for genomic integration

METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM CELLS

ANTAGONISM AS A THERAPY FOR TDP-43 PROTEINOPATHIES

COMPOSITION AND METHOD FOR REDUCING EXPRESSION OF CHECKPOINT INHIBITORS IN T CELLS EXPRESSING A CAR OR CTL

TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES

ENHANCED PRODUCTION OF HISTIDINE, PURINE PATHWAY METABOLITES, AND PLASMID DNA

4′-phosphate analogs and oligonucleotides comprising the same

ANTISENSE MOLECULES AND METHODS FOR TREATING PATHOLOGIES

COMPOSITION FOR SIMULTANEOUSLY MODIFYING AMINO ACIDS OF SITE 736 AND SITE 738 OF PAPN GENE AND APPLICATION THEREOF

UNIVERSAL DYNAMIC PHARMACOKINETIC-MODIFYING ANCHORS

STABLE TARGET-EDITING GUIDE RNA HAVING CHEMICALLY MODIFIED NUCLEIC ACID INTRODUCED THEREINTO

LEAPER TECHNOLOGY BASED METHOD FOR TREATING MPS IH AND COMPOSITION

NEW METHOD FOR TARGETED EDITING OF RNA

Methods of Treatment of Neurofibromatosis Type 1 (NF1) and NF-1 Mediated Conditions and Compositions for Use in Such Methods

Antisense Oligonucleotides Targeting ATXN3

Modulation Of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2)-Mediated Immune Response

Methods and compositions for modulating splicing

ANTISENSE GUIDE RNA WITH ADDED FUNCTIONAL REGION FOR EDITING TARGET RNA

TRANSPOSITION-BASED DIAGNOSTICS METHODS AND DEVICES

CHARACTERIZING OLIGONUCLEOTIDES

Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA

SWITCHABLE CAS9 NUCLEASES AND USES THEREOF

Compositions and methods for modulating complement factor B expression

RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER

METHOD FOR SUPPRESSING METHYLATION OF TARGET DNA IN PLANT

NOVEL PRECURSOR MIRNA AND APPLICATION THEREOF IN TUMOR TREATMENT

COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION

INHIBITION OF DENND5B EXPRESSION FOR TREATING HEPATIC STEATOSIS

Antisense Oligonucleotides Targeting ATXN3

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION

Engineered class 2 type V CRISPR systems

METHOD FOR PURIFYING UCART CELL AND USE THEREOF

Directed editing of cellular RNA via nuclear delivery of CRISPR/Cas9

NUCLEIC ACID-PEPTIDE-NUCLEIC ACID CONJUGATE MOLECULES AND METHODS OF MAKING THE SAME

NR4A-DEFICIENT CELLS EXPRESSING C-JUN AND USES THEREOF

COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER

crRNA:tracrRNA-BASED BINARY LOGIC GATE DESIGN AS A TOOL FOR SYNTHETIC BIOLOGY

USE OF POTASSIUM CHANNEL INHIBITOR FOR TREATING DEPRESSION

MODIFIED DOUBLE STRANDED OLIGONUCLEOTIDE

Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

CATALYTIC NUCLEIC ACID-BASED GENETIC ENGINEERING METHOD

PLATELETS TRANSFECTED BY EXOGENOUS GENETIC MATERIAL AND PLATELET MICROPARTICLES OBTAINED BY SAID TRANSFECTED PLATELETS, METHOD FOR THE PREPARATION AND USES THEREOF

CRISPR-ASSOCIATED TRANSPOSON SYSTEMS AND METHODS OF USING SAME

Polynucleotide compositions and methods for gene expression regulations

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

Phosphorodiamidate morpholino oligomers

TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY

ANTISENSE NUCLEIC ACID ENABLING EXON SKIPPING

Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy

Pooled Crispr Inverse PCR Sequencing (PCIP-Seq): Simultaneous Sequencing of Viral Insertion Points and the Integrated Viral Genomes with Long Reads

APOE GENE THERAPY

METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS

METHODS FOR THE TREATMENT OF TRINUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MLH3 ACTIVITY

COMPOSITIONS AND METHODS FOR MODULATING ATAXIN 3 EXPRESSION

MICRO-RNA PROFILING, COMPOSITIONS, AND METHODS OF TREATING DISEASES

ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER STEM CELLS

METHODS FOR THE TREATMENT OF EPILEPSY

Modified EC7 Cells Having Low Toxicity to Viral Production Payloads

TARGETING MICRORNA FOR CANCER TREATMENT

METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM

METHOD FOR IDENTIFYING REGULATORY ELEMENTS CONFORMATIONALLY

ENGINEERING CIRCULAR GUIDE RNAS

COMPOSITIONS AND METHODS FOR CONTROLLING LEPTINOTARSA

CULTURES OF AND METHODS OF MANUFACTURING SQUAMOUS CELL CARCINOMA CELLS

METHODS OF MULTI-SPECIES INSECT PEST CONTROL

Treatment Of Cognitive Impairment With Alpha-N-Acetylgalactosaminide Alpha-2,6-Sialyltransferase 5 (ST6GALNAC5) Inhibitors

SMALL RIBOSOMAL PROTEIN SUBUNIT 25 (RPS25) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Compositions and methods for delivery of nucleic acids to cells

STABILIZED HNF4A SARNA COMPOSITIONS AND METHODS OF USE

TARGETING GLIOBLASTOMA STEM CELLS THROUGH THE TLX-TET3 AXIS

METHOD FOR DETECTING TARGET NUCLEIC ACID, METHOD FOR DETECTING NUCLEIC ACID-BINDING MOLECULE, AND METHOD FOR EVALUATING NUCLEIC ACID-BINDING ABILITY

RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

BODY FAT REDUCING AGENT AND METHOD FOR SCREENING FOR SUBSTANCE CAPABLE OF REDUCING BODY FAT

Tunable Reversir™ compounds

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

ALS TREATMENT METHOD, ALS PHARMACEUTICAL COMPOSITION, AND ALS DIAGNOSTIC METHOD

TARGETING GENE AMPLIFICATION IN CANCER USING TRIPLEX FORMATION AS A THERAPEUTIC STRATEGY

APOLIPOPROTEIN B ANTAGONIST

Implantable Medical Device for the Delivery of a Nucleic Acid

Treatment of Hypertension With Solute Carrier Family 9 Isoform A3 Regulatory Factor 2 (SLC9A3R2) Inhibitors

Inhibitors of Cancer Biomarkers and Uses Thereof

Compositions and methods for organ specific delivery of nucleic acids